Last 12 months
Inside the activity.
0 purchase rows · 223 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 20 |
| Jan 2026 | 0 | 24 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 29 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 15 |
| Jul 2026 | 0 | 60 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 18 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 02, 2022 Filed May 5, 2022 01:21 UTC |
JANAC K CHARLESDirector · President & CEO
|
Tax withholdingCommon Stock | 2,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009542 · form4.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,564 F1 · balance_after: Includes 50,564 restricted stock units. Read SEC document |
| May 02, 2022 Filed May 5, 2022 01:32 UTC |
Munce Claudia F.Director
|
GrantCommon Stock | 22,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009545 · form4.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,314 F1 · shares: Includes 22,314 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 36 equal monthly installments from June 2, 2022. The RSUs have no expiration date. Read SEC document |
| May 02, 2022 Filed May 5, 2022 01:24 UTC |
Moll Laurent RChief Operating Officer
|
Tax withholdingCommon Stock | 1,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009543 · form4.xml · nonDerivative · entry 1 Moll Laurent R · CIK 0001888601 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 662,822 F1 · balance_after: Includes 640,032 restricted stock units. Read SEC document |
| May 02, 2022 Filed May 5, 2022 00:50 UTC |
Hawkins Nicholas B.VP and Chief Financial Officer
|
Tax withholdingCommon Stock | 799 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009534 · form4.xml · nonDerivative · entry 1 Hawkins Nicholas B. · CIK 0001549550 · VP and Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,340 F1 · balance_after: Includes 17,736 restricted stock units. Read SEC document |
| May 02, 2022 Filed May 4, 2022 23:49 UTC |
Alpern Paul LVP and General Counsel
|
Tax withholdingCommon Stock | 460 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-009529 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,456 F1 · balance_after: Includes 10,456 restricted stock units. Read SEC document |
| May 02, 2022 Filed Nov 23, 2022 21:12 UTC Amendment |
Munce Claudia F.Director
|
GrantCommon Stock | 22,314 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-020843 · doc1.xml · nonDerivative · entry 1 Munce Claudia F. · CIK 0001668897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,314 F1 · shares: The original form 4 inadvertently included the incorrect vesting schedule for the restricted stock units ("RSUs"). This amendment is being filed to correctly report the vesting schedule. Reflects 22,314 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in 3 equal annual installments starting on 5/1/2023 . The RSUs have no expiration date. F2 · balance_after: Includes 22,314 RSUs. Read SEC document |
| April 05, 2022 Filed Aug 3, 2022 21:27 UTC |
RAZA SAIYED ATIQDirector
|
GrantCommon Stock | 1,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014891 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,847 F1 · shares: Fully vested restricted stock. The restricted stock represent retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. Read SEC document |
| April 05, 2022 Filed Dec 27, 2022 21:35 UTC |
Geday Isabelle FDirector
|
GrantCommon Stock | 453 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-008433 · primarydocument.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,367 F1 · shares: Fully vested restricted stock. The restricted stock represents retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash. The Reporting Person elected to defer receipt of the shares. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 22:54 UTC |
Moll Laurent RChief Operating Officer
|
Tax withholdingCommon Stock | 12,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007169 · doc1.xml · nonDerivative · entry 1 Moll Laurent R · CIK 0001888601 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663,934 F1 · balance_after: Includes 641,144 restricted stock units. Read SEC document |
| February 01, 2022 Filed Feb 3, 2022 02:14 UTC |
Geday Isabelle FDirector · VP and GM, IP Employment Div.
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-002403 · doc1.xml · nonDerivative · entry 1 Geday Isabelle F · CIK 0001888675 · Director · VP and GM, IP Employment Div. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,450 F1 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RUSs will fully (100%) vest upon the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to continued service to the Company through each such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 68,450 RSUs. Read SEC document |
| November 12, 2021 Filed Nov 23, 2022 21:13 UTC |
RAZA SAIYED ATIQDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 20,833 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001567619-22-020845 · doc1.xml · derivative · entry 3 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 20,833 shares Expires 2030-04-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| November 12, 2021 Filed Nov 23, 2022 21:13 UTC |
RAZA SAIYED ATIQDirector
|
Exercise / conversionCommon Stock | 20,833 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-020845 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The shares subject to the stock option will vest and become exercisable in 36 substantially equal installments commencing on May 23, 2020. Read SEC document |
| November 11, 2021 Filed Nov 15, 2021 22:26 UTC |
Viana Antonio JDirector
|
GrantCommon Stock | 1 | $21.05 | $21.05 |
DisclosureSEC source: 0001567619-21-020516 · doc1.xml · nonDerivative · entry 1 Viana Antonio J · CIK 0001888686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,001 F1 · balance_after: Includes 6,250 restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 19, 2021 23:59 UTC |
JANAC K CHARLESDirector · President & CEO
|
GrantCommon Stock | 52,971 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020901 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,971 F1 · shares: Includes 52,971 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 52,971 restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 19, 2021 23:57 UTC |
Alpern Paul LVP and General Counsel
|
GrantCommon Stock | 10,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020900 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,941 F1 · shares: Includes 10,941 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 10,941 restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 19, 2021 23:55 UTC |
Hawkins Nicholas B.VP and Chief Financial Officer
|
GrantCommon Stock | 18,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020899 · doc1.xml · nonDerivative · entry 1 Hawkins Nicholas B. · CIK 0001549550 · VP and Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,182 F1 · shares: Includes 18,578 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 18,578 restricted stock units. Read SEC document |
| November 11, 2021 Filed Nov 19, 2021 23:54 UTC |
Moll Laurent RChief Operating Officer
|
GrantCommon Stock | 25,998 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020898 · doc1.xml · nonDerivative · entry 1 Moll Laurent R · CIK 0001888601 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,998 F1 · shares: Includes 25,998 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 675,998 restricted stock units Read SEC document |
| November 11, 2021 Filed Jan 14, 2022 23:02 UTC Amendment |
JANAC K CHARLESDirector · President & CEO
|
GrantCommon Stock | 52,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001216 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,849 F1 · shares: The original form 4 inadvertently overstated the number of restricted stock units ("RSUs") awarded. This amendment is being filed to correctly report the number of RSUs earned and the total number of shares beneficially owned following the reported transaction. Reflects 52,849 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 52,849 restricted stock units. Read SEC document |
| November 11, 2021 Filed Jan 14, 2022 22:57 UTC Amendment |
Moll Laurent RChief Operating Officer
|
GrantCommon Stock | 25,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001215 · doc1.xml · nonDerivative · entry 1 Moll Laurent R · CIK 0001888601 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 675,938 F1 · shares: The original form 4 inadvertently overstated the number of restricted stock units ("RSUs") awarded. This amendment is being filed to correctly report the number of RSUs earned and the total number of shares beneficially owned following the reported transaction. Reflects 25,938 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 675,938 restricted stock units. Read SEC document |
| November 11, 2021 Filed Jan 14, 2022 22:51 UTC Amendment |
Hawkins Nicholas B.VP and Chief Financial Officer
|
GrantCommon Stock | 18,535 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001214 · doc1.xml · nonDerivative · entry 1 Hawkins Nicholas B. · CIK 0001549550 · VP and Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,139 F1 · shares: The original form 4 inadvertently overstated the number of restricted stock units ("RSUs") awarded. This amendment is being filed to correctly report the number of RSUs earned and the total number of shares beneficially owned following the reported transaction. Reflects 18,535 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 18,535 restricted stock units. Read SEC document |
| November 11, 2021 Filed Jan 14, 2022 22:48 UTC Amendment |
Alpern Paul LVP and General Counsel
|
GrantCommon Stock | 10,916 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-001213 · doc1.xml · nonDerivative · entry 1 Alpern Paul L · CIK 0001888542 · VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,916 F1 · shares: The original form 4 inadvertently overstated the number of restricted stock units ("RSUs") awarded. This amendment is being filed to correctly report the number of RSUs earned and the total number of shares beneficially owned following the reported transaction. Reflects 10,916 RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest with respect to 12.5% of the total RSUs on 5/1/2022 and in equal quarterly installments thereafter. The RSUs have no expiration date. F2 · balance_after: Includes 10,916 restricted stock units. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 20:28 UTC |
Claussen ChristianDirector
|
ConversionSeries A Preferred Stock · Derivative | 3,127,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019035 · doc1.xml · derivative · entry 3 Claussen Christian · CIK 0001889608 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,127,907 Underlying: Common Stock · 3,127,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The reporting person is a General Partner of Ventech Capital F ("Ventech"). Investment and voting decisions for Ventech are made by Ventech's investment committee, which is governed by a non-executive board comprised of three or more individuals, and therefore the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 29, 2021 Filed Oct 29, 2021 20:28 UTC |
Claussen ChristianDirector
|
ConversionCommon Stock | 3,127,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-019035 · doc1.xml · nonDerivative · entry 1 Claussen Christian · CIK 0001889608 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,127,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The reporting person is a General Partner of Ventech Capital F ("Ventech"). Investment and voting decisions for Ventech are made by Ventech's investment committee, which is governed by a non-executive board comprised of three or more individuals, and therefore the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 29, 2021 Filed Oct 30, 2021 00:39 UTC |
Cantwell Wayne CDirector
|
ConversionSeries A Preferred Stock · Derivative | 38,760 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · derivative · entry 4 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Crescendo Ventures 401K Profit Sharing Plan FBO Wayne Cantwell Disclosed balance after: 38,760 Underlying: Common Stock · 38,760 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 29, 2021 Filed Oct 30, 2021 00:39 UTC |
Cantwell Wayne CDirector
|
PurchaseCommon Stock | 1 | $18.75 | $18.75 |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · nonDerivative · entry 2 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Crescendo Ventures 401K Profit Sharing Plan FBO Wayne Cantwell Disclosed balance after: 38,761 Read SEC document |
| October 29, 2021 Filed Oct 30, 2021 00:39 UTC |
Cantwell Wayne CDirector
|
ConversionCommon Stock | 38,760 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · nonDerivative · entry 1 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By: Crescendo Ventures 401K Profit Sharing Plan FBO Wayne Cantwell Disclosed balance after: 38,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:15 UTC |
Bayview Legacy, LLC10% owner
|
ConversionSeries A Preferred Stock · Derivative | 335,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019220 · doc1.xml · derivative · entry 2 Arteris IP, LLC · CIK 0001888862 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,891 Underlying: Common Stock · 335,891 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Preferred Stock will automatically convert into shares of the Issuer's Common Stock on a 1 to 1 basis for no additional consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date. F1 · derivative.exercise_date: The Issuer's Preferred Stock will automatically convert into shares of the Issuer's Common Stock on a 1 to 1 basis for no additional consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date. F1 · derivative.expiration_date: The Issuer's Preferred Stock will automatically convert into shares of the Issuer's Common Stock on a 1 to 1 basis for no additional consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date. F2 · ownership.direct: K. Charles Janac is the manager of Arteris IP, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Arteris IP, LLC. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:15 UTC |
Bayview Legacy, LLC10% owner
|
ConversionCommon Stock | 335,891 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-019220 · doc1.xml · nonDerivative · entry 1 Arteris IP, LLC · CIK 0001888862 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,335,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's Preferred Stock will automatically convert into shares of the Issuer's Common Stock on a 1 to 1 basis for no additional consideration upon the closing of the Issuer's initial public offering. The shares have no expiration date. F2 · ownership.nature: K. Charles Janac is the manager of Arteris IP, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Arteris IP, LLC. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:13 UTC |
Ventech Capital F10% owner
|
ConversionSeries A Preferred Stock · Derivative | 3,127,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019219 · doc1.xml · derivative · entry 2 Ventech Capital F · CIK 0001888725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 3,127,907 Underlying: Common Stock · 3,127,907 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The reporting person is a General Partner of Ventech Capital F ("Ventech"). Investment and voting decisions for Ventech are made by Ventech's investment committee, which is governed by a non-executive board comprised of three or more individuals, and therefore the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 21:13 UTC |
Ventech Capital F10% owner
|
ConversionCommon Stock | 3,127,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-019219 · doc1.xml · nonDerivative · entry 1 Ventech Capital F · CIK 0001888725 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,127,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.direct: The reporting person is a General Partner of Ventech Capital F ("Ventech"). Investment and voting decisions for Ventech are made by Ventech's investment committee, which is governed by a non-executive board comprised of three or more individuals, and therefore the reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, if any. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC |
JANAC K CHARLESDirector · President & CEO
|
ConversionSeries A Preferred Stock · Derivative | 335,891 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · derivative · entry 5 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Arteris IP, LLC Disclosed balance after: 335,891 Underlying: Common Stock · 335,891 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The Reporting Person is the manager of Arteris IP, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Arteris IP, LLC. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC |
JANAC K CHARLESDirector · President & CEO
|
ConversionSeries A Preferred Stock · Derivative | 77,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · derivative · entry 4 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Janac Trust Disclosed balance after: 77,286 Underlying: Common Stock · 77,286 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.exercise_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · derivative.expiration_date: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC |
JANAC K CHARLESDirector · President & CEO
|
ConversionCommon Stock | 335,891 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · nonDerivative · entry 2 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Arteris IP, LLC Disclosed balance after: 10,335,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F2 · ownership.nature: The Reporting Person is the manager of Arteris IP, LLC and as such is deemed to have voting and dispositive power of the shares beneficially owned by Arteris IP, LLC. Read SEC document |
| October 29, 2021 Filed Nov 19, 2021 23:53 UTC |
JANAC K CHARLESDirector · President & CEO
|
ConversionCommon Stock | 77,286 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001567619-21-020897 · doc1.xml · nonDerivative · entry 1 JANAC K CHARLES · CIK 0001068987 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By the Janac Trust Disclosed balance after: 77,286 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. F1 · price: Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date. Read SEC document |
| October 26, 2021 Filed Oct 29, 2021 20:28 UTC |
Claussen ChristianDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019035 · doc1.xml · nonDerivative · entry 2 Claussen Christian · CIK 0001889608 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F3 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F4 · balance_after: Includes 6,250 restricted stock units. Read SEC document |
| October 26, 2021 Filed Oct 30, 2021 00:23 UTC |
Viana Antonio JDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019034 · doc1.xml · nonDerivative · entry 1 Viana Antonio J · CIK 0001888686 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 F1 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 6,250 restricted stock units. Read SEC document |
| October 26, 2021 Filed Oct 30, 2021 00:35 UTC |
Chitkara RamanDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019036 · doc1.xml · nonDerivative · entry 1 Chitkara Raman · CIK 0001748459 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,250 F1 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 72,250 restricted stock units. Read SEC document |
| October 26, 2021 Filed Oct 30, 2021 00:39 UTC |
Cantwell Wayne CDirector
|
GrantCommon Stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019038 · doc1.xml · nonDerivative · entry 3 Cantwell Wayne C · CIK 0001888679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,333 F2 · shares: Includes 8,333 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F3 · balance_after: Includes 58,333 restricted stock units. Read SEC document |
| October 26, 2021 Filed Oct 30, 2021 00:36 UTC |
RAZA SAIYED ATIQDirector
|
GrantCommon Stock | 6,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-019037 · doc1.xml · nonDerivative · entry 1 RAZA SAIYED ATIQ · CIK 0001184563 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 F1 · shares: Includes 6,250 restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) the first anniversary of the grant date and (ii) immediately before the Annual Meeting following the grant date, subject to the reporting person continuing to provide services to Issuer's Board through such vesting date. The RSUs have no expiration date. F2 · balance_after: Includes 6,250 restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.